About Medcannova
Leading the global advancement of medical cannabis research, pharmaceutical innovation, and therapeutic development.
Our Approach
Evidence-Based Research
We ground all work in rigorous scientific methodology, peer-reviewed literature, and clinical validation. Our research standards exceed international pharmaceutical requirements.
Regulatory Excellence
We navigate complex regulatory landscapes across 14+ jurisdictions with expertise in GMP standards, clinical trial protocols, and pharmaceutical compliance.
Therapeutic Innovation
We develop novel delivery systems, formulations, and therapeutic applications that advance patient outcomes and expand treatment options.
Research & Development
Our R&D initiatives focus on cannabinoid pharmacology, formulation science, delivery mechanisms, and clinical efficacy validation.
Cannabinoid Science
Advanced research into cannabinoid interactions, pharmacokinetics, and therapeutic mechanisms for various medical conditions.
Formulation Development
Cutting-edge work in pharmaceutical formulations, including novel delivery systems and standardized therapeutic products.
Clinical Validation
Comprehensive clinical trial programs designed to establish safety, efficacy, and optimal dosing for cannabis-based therapeutics.
Global Operations
Medcannova operates across multiple continents with expertise in diverse regulatory environments and healthcare systems.
Operational Markets
Additional markets under development with regulatory frameworks being established.
Regulatory & Compliance Framework
GMP Standards
All manufacturing facilities comply with Good Manufacturing Practice (GMP) standards and international pharmaceutical quality requirements.
Clinical Research
Clinical trials follow ICH-GCP guidelines, FDA regulations, and EMA requirements for rigorous safety and efficacy evaluation.
Quality Assurance
Comprehensive quality control, analytical testing, and continuous monitoring ensure product safety and consistency across all markets.
Key Focus Areas
Chronic Pain Management
Research and development of cannabis-based therapeutics for chronic pain conditions, neuropathic pain, and post-operative pain management.
Neurological Disorders
Investigation of cannabinoid therapies for epilepsy, multiple sclerosis, Parkinson's disease, and other neurological conditions.
Oncology Support
Development of cannabis-based supportive care therapies for cancer patients, including symptom management and quality of life improvement.
Mental Health
Research into cannabinoid applications for anxiety, depression, PTSD, and other mental health conditions with clinical validation.
Inflammatory Conditions
Therapeutic development for inflammatory bowel disease, rheumatoid arthritis, and other inflammatory conditions.
Sleep Disorders
Investigation of cannabis-based therapeutics for insomnia, sleep apnea, and other sleep-related disorders.
Interested in Collaboration?
Reach out to discuss research partnerships, regulatory consulting, or clinical trial opportunities.
Contact Us